home

Institutional Biosafety Committee

template_global_naviagation                   Forms    Researcher Manual  (updated 3/13/13)

INTRODUCTION:

The University of Vermont (UVM), in accordance with the Department of Health and Human Services Guidelines for Research Involving Recombinant DNA Molecules, has established an Institutional Biosafety Committee (IBC) to oversee research that involves Recombinant DNA, Infectious Agents and toxins at this institution. All faculty, staff, students or users of the facilities at UVM who are contemplating use of recombinant DNA research must comply with these Guidelines. All protocols, in which recombinant DNA will be used, regardless of the funding source, must be submitted to the Institutional Biosafety Committee for review.

The IBC is reviewing the use of infectious agents in addition to the use of recombinant DNA. We are currently revising our forms, guidelines and processes in preparation for this. Risk Management will continue to oversee chemical and biological safety.

 

  INSTITUTIONAL BIOSAFETY COMMITTEE Tel: (802) 656-5040
  University of Vermont - Research Protections Office Email: ibc@uvm.edu
  213 Waterman Building  
  85 South Prospect Street  
  Burlington, VT 05405  

 

Last modified June 27 2011 12:36 PM

Contact UVM © 2013 The University of Vermont - Burlington, VT 05405 - (802) 656-3131